IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $202,000 | -66.3% | 5,073 | -49.3% | 0.00% | -66.7% |
| Q3 2019 | $599,000 | -6.8% | 10,000 | 0.0% | 0.01% | -29.4% |
| Q2 2019 | $643,000 | -47.2% | 10,000 | -33.3% | 0.02% | -43.3% |
| Q1 2019 | $1,218,000 | +12.7% | 15,000 | -25.0% | 0.03% | -33.3% |
| Q4 2018 | $1,081,000 | -16.5% | 20,000 | -20.4% | 0.04% | +32.4% |
| Q3 2018 | $1,295,000 | +24.3% | 25,116 | +0.5% | 0.03% | +36.0% |
| Q2 2018 | $1,042,000 | -5.4% | 25,000 | 0.0% | 0.02% | -28.6% |
| Q1 2018 | $1,102,000 | +9.5% | 25,000 | +25.0% | 0.04% | +34.6% |
| Q4 2017 | $1,006,000 | +66.8% | 20,000 | +33.3% | 0.03% | +8.3% |
| Q1 2017 | $603,000 | +26.2% | 15,000 | +50.0% | 0.02% | +4.3% |
| Q4 2016 | $478,000 | +30.6% | 10,000 | 0.0% | 0.02% | 0.0% |
| Q3 2016 | $366,000 | +80.3% | 10,000 | +100.0% | 0.02% | +155.6% |
| Q1 2016 | $203,000 | – | 5,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |